Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 12—December 2007
Dispatch

Risk Factors for West Nile Virus Neuroinvasive Disease, California, 2005

Cynthia M. Jean*Comments to Author , Somayeh Honarmand*, Janice K. Louie*, and Carol A. Glaser*
Author affiliations: *California Department of Public Health, Richmond, California, USA;

Main Article

Table 1

Characteristics of WNV cases reported in California, 2005*

Characteristic WNND, no./total (%) WNF, no./total (%) 95% Confidence interval p value†
Sex, M 188/305 (62) 270/534 (51) 1.18–2.09 <0.01
Age, y
<18 12/305 (4) 19/534 (4) 0.53–2.32 0.85
18–44 73/305 (24) 180/534 (34) 0.45–0.85 <0.01
45–64 121/305 (40) 240/534 (45) 0.61–1.07 0.15
65–74 51/305 (17) 61/534 (11) 1.09–2.33 0.03
>75
48/305 (16)
33/534 (6)
1.78–4.53
<0.0001
Symptom
  Fever 254/283 (90) 315/456 (69) 2.54–6.04 <0.0001
  Headache 202/262 (77) 387/483 (80) 0.58–1.20 0.33
  Rash 54/244 (22) 239/469 (51) 0.19–0.39 <0.0001
  Muscle pain/weakness 215/274 (78) 393/485 (81) 0.59–1.23 0.40
  Seizures 11/153 (7) 2/313 (0.6) 2.64–55.06 0.001
  Altered mental status 148/275 (54) 68/463 (15) 4.77–9.61 <0.0001

*WNV, West Nile virus; WNND, West Nile neuroinvasive disease; WNF, West Nile fever.
†Fisher exact test, 2-tailed.

Main Article

Page created: July 06, 2010
Page updated: July 06, 2010
Page reviewed: July 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external